Home › Trial NCT00264017
Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis
- Trial IDNCT00264017
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorDattoli Cancer Center and Brachytherapy Research Institute
- Enrollment60
- Start date2005-11
- ConditionsProstate Cancer Patients Undergoing External Radiation and Seed Implantation
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.